Persistent syphilitic ocular manifestations despite treatment: a case series

Sairi Zhang1, Kaersti L Rickels1, Vignesh Krishnan1

  • 1College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Abstract

Insights

Persistent ocular syphilis requires careful management. Ensure complete penicillin treatment and declining RPR titers for effective management, followed by anti-inflammatory therapy if needed for visual recovery.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Immunology

Background:

  • Penicillin is the gold standard for syphilis treatment.
  • Ocular syphilis can cause persistent posterior segment inflammation and vision loss.
  • This case series examines persistent syphilitic ocular manifestations.

Purpose of the Study:

  • To describe three cases of persistent ocular syphilis.
  • To highlight challenges in managing treatment-resistant cases.
  • To provide recommendations for managing persistent syphilitic ocular manifestations.

Main Methods:

  • Three patients with persistent ocular syphilis were treated with intravenous penicillin and oral prednisone.
  • Case 1 involved syphilitic outer retinopathy (SOR), papillitis, and acute syphilitic posterior placoid chorioretinopathy (ASPPC) with persistent cystoid macular edema (CME).
  • Cases 2 and 3 involved persistent SOR, ASPPC, and papillitis, with one patient experiencing reinfection.

Main Results:

  • Persistent cystoid macular edema (CME) required intravitreal triamcinolone and ketorolac drops in Case 1.
  • Incomplete penicillin treatment in Case 2 led to persistent SOR, requiring retreatment with doxycycline and prednisone.
  • Case 3 demonstrated recurrent ASPPC and persistent papillitis, necessitating retreatment for reinfection.

Conclusions:

  • Complete penicillin treatment and declining RPR titers are crucial for managing persistent ocular syphilis.
  • Anti-inflammatory therapy is recommended for persistent ocular inflammation after ensuring adequate treatment.
  • Factors like delayed treatment, poor initial vision, macular edema, and HIV coinfection worsen visual prognosis.